{"mainPropery":{"diseaseId":3843,"diseaseName":"Congenital muscular dystrophy type 1A","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3843/congenital-muscular-dystrophy-type-1a","synonyms":["Merosin-negative congenital muscular dystrophy","Merosin-deficient congenital muscular dystrophy","Muscular dystrophy, congenital, merosin-deficient","MDC1A","Laminin alpha-2 deficiency","LAMA2-related muscular dystrophy"],"synonyms-with-source":[{"name":"Merosin-negative congenital muscular dystrophy"},{"name":"Merosin-deficient congenital muscular dystrophy"},{"name":"Muscular dystrophy, congenital, merosin-deficient"},{"name":"MDC1A"},{"name":"Laminin alpha-2 deficiency"},{"name":"LAMA2-related muscular dystrophy","source":"GHR"}],"identifiers":[{"identifierType":"OMIM","identifierId":"607855"},{"identifierType":"ORPHANET","identifierId":"258"},{"identifierType":"UMLS","identifierId":"C1263858"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":87,"resourceName":"Muscular Dystrophy Family Foundation","abbreviation":"","address1":"P.O. Box 776","address2":"","address3":"","address4":"","address5":"","city":"Carmel","state":"IN","zip":"46082","country":"United States","phone":"+1-317-615-9140","tty":"","tollFree":"","fax":"","email":"info@mdff.org","url":"https://mdff.org/","freeText":"MDFF provides financial assistance, quality programs and services for the Muscular Dystrophy community in Indiana."},{"resourceID":724,"resourceName":"Cure CMD - Congenital Muscular Dystrophy","abbreviation":"","address1":"19401 S. Vermont Ave., Suite J100","address2":"","address3":"","address4":"","address5":"","city":"Torrance","state":"CA","zip":"90502","country":"United States","phone":"323-250-2399 or 424-265-0874","tty":"","tollFree":"","fax":"","email":"info@curecmd.org","url":"https://www.curecmd.org/","freeText":""},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""},{"resourceID":936,"resourceName":"Muscular Dystrophy UK","abbreviation":"","address1":"61A Great Suffolk Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" SE1 0BU","country":"United Kingdom","phone":" (+44) 0 020 7803 4800","tty":"","tollFree":"0800 652 6352 (Helpline)","fax":"","email":"info@musculardystrophyuk.org","url":"https://www.musculardystrophyuk.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/607855' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=607855' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Congenital muscular dystrophy type 1A. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?term=congenital+muscular+dystrophy' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Congenital muscular dystrophy type 1A. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/lama2-related-muscular-dystrophy' target='_blank'>Genetics Home Reference</a> contains information on Congenital muscular dystrophy type 1A. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1196/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/md/detail_md.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1180214-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022450' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=258' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1291/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='http://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/87-merosin-deficient-congenital-muscular-dystrophy.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:258' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Congenital muscular dystrophy type 1A. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Congenital muscular dystrophy type 1A:<br />\r\n<a href='https://www.cmdir.org/' target='_blank'>Congenital Muscle Disease International Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":5354,"questionText":"What is congenital muscular dystrophy type 1A?","answerText":"<strong>Congenital muscular dystrophy type 1A (MDC1A)</strong> belongs to a group of neuromuscular disorders that beings at birth or infancy and is characterized mainly by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" target=_blank>hypotonia</a>, muscle weakness and muscle wasting.&nbsp;Other signs and symptoms include&nbsp;rigidity of the spine; <a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=_blank>scoliosis</a>; and delayed, limited motor development, with most individuals needing assistive devices for mobility. Respiratory&nbsp;problems,&nbsp;feeding disorders and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a> may also occur. With time, affected individuals may develop an elongated face and ophthalmoplegia disorders (paralysis or weakness in muscles of the eye). Intellectual development is typically normal. The prognosis is poor, as many affected children do not reach adolescence. It is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/LAMA2\" target=_blank><em>LAMA2</em></a> gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> manner. Treatment is generally symptomatic and includes a multidisciplinary approach.[4412]","dateModified":"2011-09-26T12:56:00"},"basicQuestions":[{"questionId":5355,"questionText":"What are the signs and symptoms of congenital muscular dystrophy type 1A?","answerText":"Infants with congenital muscular dystrophy type 1A (MDC1A) typically have poor muscle tone (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" target=_blank>hypotonia</a>) and muscle weakness at birth. Within weeks after birth, some affected infants may have feeding and respiratory difficulties. Motor development is often delayed and limited. Most affected infants can sit unsupported and some can stand without assistance. Only a few children with MDC1A are eventually able to walk unassisted.[4414] Additional signs and symptoms that affected individuals may experience include joint contractures (stiff or \"frozen\" joints), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/9216.htm\" target=_blank>congenital hip dislocation</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=_blank>scoliosis</a>, and ophthalmoplegia (paralysis or weakness in the muscles of the eye).[4414] Affected children may also develop an elongated face. Approximately 20-30% experience <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>.[4413] The majority of affected individuals have normal&nbsp;intellectual abilities.[4413] The prognosis of this condition is poor, as many affected children do not reach adolescence.[4412]<br><br>Although most individuals affected with MDC1A have complete deficiency of the merosin protein, a few individuals have only a partial deficiency. Among individuals with a partial deficiency, the severity and age of onset&nbsp;varies greatly.[4413] One study reported that approximately 12% of individuals have later onset, slowly progressive weakness.[4415]","dateModified":"2011-09-26T14:13:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4412,"authors":"M. Fardeau","articleTitle":"Congenital muscular dystrophy type 1A","bookWebsiteJournalTitle":"Orphanet","date":"April 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=258","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4413,"authors":"Susan Sparks et al","articleTitle":"Congenital Muscular Dystrophy Overview","bookWebsiteJournalTitle":"GeneReviews","date":"January 4, 2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK1291/","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4414,"authors":"","articleTitle":"Congenital Muscular Dystrophy","bookWebsiteJournalTitle":"NORD","date":"January 6, 2010","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1196/viewAbstract","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4415,"authors":"K. Jones et al","articleTitle":"The expanding phenotype of laminin a2 chain (merosin) abnormalities: case series and review","bookWebsiteJournalTitle":"J Med Genet","date":"October 2001","volume":"38(10)","pages":"649-657"}]},{"questionId":5356,"questionText":"How might congenital muscular dystrophy type 1A be treated?","answerText":"There is currently no cure&nbsp;for congenital muscular dystrophy type 1A (MDC1A) and treatment generally focuses on managing the individual signs and symptoms of the condition. A multidisciplinary&nbsp;approach is often needed and may improve the quality and longevity of life. This may include a joint effort&nbsp;by orthopedic and respiratory specialists; physiotherapists; occupational therapists; and speech-language therapists. The main objective is&nbsp;helping each affected individual reach their full potential. Seizures or other neurological complications may require specific treatment. The prognosis of this condition is poor, as many affected children do not reach adolescence.[4412]","dateModified":"2011-09-26T14:15:00","resourceClassificationName":"Treatment","references":[{"referenceId":4412,"authors":"M. Fardeau","articleTitle":"Congenital muscular dystrophy type 1A","bookWebsiteJournalTitle":"Orphanet","date":"April 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=258","dateAccessed":"2011-09-26T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":9138,"relatedDiseaseName":"Congenital muscular dystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":32332,"abbreviatedInquiry":"I am a school nurse and have a new student attending our school with this diagnosis. I would&nbsp;like to learn more about the disease and what we can do to make this student as comfortable as possible.","caseQuestions":[{"questionId":5354,"questionText":"What is congenital muscular dystrophy type 1A?","answerText":"<strong>Congenital muscular dystrophy type 1A (MDC1A)</strong> belongs to a group of neuromuscular disorders that beings at birth or infancy and is characterized mainly by <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" target=_blank>hypotonia</a>, muscle weakness and muscle wasting.&nbsp;Other signs and symptoms include&nbsp;rigidity of the spine; <a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=_blank>scoliosis</a>; and delayed, limited motor development, with most individuals needing assistive devices for mobility. Respiratory&nbsp;problems,&nbsp;feeding disorders and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a> may also occur. With time, affected individuals may develop an elongated face and ophthalmoplegia disorders (paralysis or weakness in muscles of the eye). Intellectual development is typically normal. The prognosis is poor, as many affected children do not reach adolescence. It is caused by&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=_blank>mutations</a> in the <a href=\"http://ghr.nlm.nih.gov/gene/LAMA2\" target=_blank><em>LAMA2</em></a> gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> manner. Treatment is generally symptomatic and includes a multidisciplinary approach.[4412]","dateModified":"2011-09-26T12:56:00","references":[{"referenceId":4412,"authors":"M. Fardeau","articleTitle":"Congenital muscular dystrophy type 1A","bookWebsiteJournalTitle":"Orphanet","date":"April 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=258","dateAccessed":"2011-09-26T00:00:00"}]},{"questionId":5355,"questionText":"What are the signs and symptoms of congenital muscular dystrophy type 1A?","answerText":"Infants with congenital muscular dystrophy type 1A (MDC1A) typically have poor muscle tone (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" target=_blank>hypotonia</a>) and muscle weakness at birth. Within weeks after birth, some affected infants may have feeding and respiratory difficulties. Motor development is often delayed and limited. Most affected infants can sit unsupported and some can stand without assistance. Only a few children with MDC1A are eventually able to walk unassisted.[4414] Additional signs and symptoms that affected individuals may experience include joint contractures (stiff or \"frozen\" joints), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/9216.htm\" target=_blank>congenital hip dislocation</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=_blank>scoliosis</a>, and ophthalmoplegia (paralysis or weakness in the muscles of the eye).[4414] Affected children may also develop an elongated face. Approximately 20-30% experience <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>.[4413] The majority of affected individuals have normal&nbsp;intellectual abilities.[4413] The prognosis of this condition is poor, as many affected children do not reach adolescence.[4412]<br><br>Although most individuals affected with MDC1A have complete deficiency of the merosin protein, a few individuals have only a partial deficiency. Among individuals with a partial deficiency, the severity and age of onset&nbsp;varies greatly.[4413] One study reported that approximately 12% of individuals have later onset, slowly progressive weakness.[4415]","dateModified":"2011-09-26T14:13:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4412,"authors":"M. Fardeau","articleTitle":"Congenital muscular dystrophy type 1A","bookWebsiteJournalTitle":"Orphanet","date":"April 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=258","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4413,"authors":"Susan Sparks et al","articleTitle":"Congenital Muscular Dystrophy Overview","bookWebsiteJournalTitle":"GeneReviews","date":"January 4, 2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK1291/","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4414,"authors":"","articleTitle":"Congenital Muscular Dystrophy","bookWebsiteJournalTitle":"NORD","date":"January 6, 2010","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1196/viewAbstract","dateAccessed":"2011-09-26T00:00:00"},{"referenceId":4415,"authors":"K. Jones et al","articleTitle":"The expanding phenotype of laminin a2 chain (merosin) abnormalities: case series and review","bookWebsiteJournalTitle":"J Med Genet","date":"October 2001","volume":"38(10)","pages":"649-657"}]},{"questionId":5356,"questionText":"How might congenital muscular dystrophy type 1A be treated?","answerText":"There is currently no cure&nbsp;for congenital muscular dystrophy type 1A (MDC1A) and treatment generally focuses on managing the individual signs and symptoms of the condition. A multidisciplinary&nbsp;approach is often needed and may improve the quality and longevity of life. This may include a joint effort&nbsp;by orthopedic and respiratory specialists; physiotherapists; occupational therapists; and speech-language therapists. The main objective is&nbsp;helping each affected individual reach their full potential. Seizures or other neurological complications may require specific treatment. The prognosis of this condition is poor, as many affected children do not reach adolescence.[4412]","dateModified":"2011-09-26T14:15:00","resourceClassificationName":"Treatment","references":[{"referenceId":4412,"authors":"M. Fardeau","articleTitle":"Congenital muscular dystrophy type 1A","bookWebsiteJournalTitle":"Orphanet","date":"April 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=258","dateAccessed":"2011-09-26T00:00:00"}]},{"questionId":5357,"questionText":"How might an individual with congenital muscular dystrophy type 1A be helped in a school environment?","answerText":"Children with congenital muscular dystrophy type 1A (MDC1A) often need mechanical assistive devices, such as walkers, canes, orthotics and wheelchairs; these may be used as needed around school to help ambulation and mobility. It has also been recommended that posture, while standing and sitting, be evaluated and assisted if necessary because improved posture may improve chest expansion. Assistance such as a school technical aide can help affected children increase their social involvement and productivity. Providing resources for social and emotional support is also helpful and can reduce the sense of social isolation that is common in individuals with congenital muscular dystrophies.[4413]<br><br>","dateModified":"2011-09-26T14:16:00","references":[{"referenceId":4413,"authors":"Susan Sparks et al","articleTitle":"Congenital Muscular Dystrophy Overview","bookWebsiteJournalTitle":"GeneReviews","date":"January 4, 2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK1291/","dateAccessed":"2011-09-26T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":1215,"phenoTypeName":"Absent muscle fiber merosin","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5307,"phenoTypeName":"Congenital muscular dystrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13410,"phenoTypeName":"Gastroesophageal reflux","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15376,"phenoTypeName":"Highly elevated creatine kinase","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11447,"phenoTypeName":"Hypokinesia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14222,"phenoTypeName":"Inability to walk","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3378,"phenoTypeName":"Increased connective tissue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11212,"phenoTypeName":"Muscle fiber atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6958,"phenoTypeName":"Myositis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4292,"phenoTypeName":"Respiratory failure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9400,"phenoTypeName":"Weak cry","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8742,"phenoTypeName":"Abnormal brainstem MRI signal intensity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12832,"phenoTypeName":"Abnormality of the temporomandibular joint","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7925,"phenoTypeName":"Aspiration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5205,"phenoTypeName":"Astrocytosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13855,"phenoTypeName":"Cerebral edema","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13575,"phenoTypeName":"EMG abnormality","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2766,"phenoTypeName":"Facial palsy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13534,"phenoTypeName":"Impaired mastication","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9753,"phenoTypeName":"Macroglossia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10723,"phenoTypeName":"Recurrent lower respiratory tract infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10117,"phenoTypeName":"Abnormality of visual evoked potentials","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11832,"phenoTypeName":"Atelectasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11728,"phenoTypeName":"Cognitive impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3608,"phenoTypeName":"Decreased body weight","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13680,"phenoTypeName":"Focal-onset seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13746,"phenoTypeName":"Generalized non-motor (absence) seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10993,"phenoTypeName":"Hyperlordosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7891,"phenoTypeName":"Hypoventilation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10859,"phenoTypeName":"Intercostal muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13446,"phenoTypeName":"Myopathic facies","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9405,"phenoTypeName":"Neonatal hypotonia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9794,"phenoTypeName":"Open mouth","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9185,"phenoTypeName":"Ophthalmoplegia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9389,"phenoTypeName":"Pachygyria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12170,"phenoTypeName":"Pontocerebellar atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11192,"phenoTypeName":"Protruding tongue","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12421,"phenoTypeName":"Reduced ejection fraction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9404,"phenoTypeName":"Reduced tendon reflexes","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4518,"phenoTypeName":"Sensorimotor neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13730,"phenoTypeName":"Pulmonary arterial hypertension","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14301,"phenoTypeName":"Abnormal cortical gyration","percentRanges":"-"},{"phenoTypeId":8737,"phenoTypeName":"Areflexia","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":6258,"phenoTypeName":"Congenital onset","percentRanges":"-"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","percentRanges":"-"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":4510,"phenoTypeName":"Hypointensity of cerebral white matter on MRI","percentRanges":"-"},{"phenoTypeId":7736,"phenoTypeName":"Increased endomysial connective tissue","percentRanges":"-"},{"phenoTypeId":10590,"phenoTypeName":"Kyphoscoliosis","percentRanges":"-"},{"phenoTypeId":6240,"phenoTypeName":"Muscular dystrophy","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":10695,"phenoTypeName":"Respiratory insufficiency due to muscle weakness","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Congenital_muscular_dystrophy_type_1A"}